<DOC>
	<DOCNO>NCT01335789</DOCNO>
	<brief_summary>The purpose study evaluate people frequently use marijuana respond stressful task , medication ( oxytocin ) affect response .</brief_summary>
	<brief_title>Effect Oxytocin Stress Marijuana Users</brief_title>
	<detailed_description>Stress commonly associate drug crave relapse substance-dependent individual . Several study indicate hypothalamic neuropeptides may mediate behavioral response stress . For example , preclinical clinical investigation indicate neuropeptide oxytocin exerts anxiolytic effect stress paradigm . Several study indicate oxytocin promotes trust , social bonding , calmness ; however , little known potential anxiolytic affect oxytocin marijuana-dependent individual . A preclinical study investigate effect mechanism lithium cannabinoid withdrawal rat positive finding , increase oxytocin level hypothesize moderate effect ( Cui et al , 2001 ) . Given anxiolytic nature oxytocin , may therapeutic role ameliorate negative affect commonly observe prior relapse marijuana-dependent individual , well anxiety associate marijuana withdrawal . This pilot protocol provide important preliminary data effect oxytocin stress marijuana-dependent individual .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Subjects must able provide inform consent function intellectual level sufficient allow accurate completion assessment instrument . Subjects must meet DSMIV criterion current marijuana dependence ( within past three month ) . While individual may also meet criterion abuse substance , must identify marijuana primary substance abuse must meet criterion dependence substance ( except nicotine ) within last 60 day . Subjects must consent remain abstinent drug abuse ( except nicotine marijuana ) threeday period immediately prior CTRC admission . Subjects must abstain marijuana 24 hour prior test . By restrict marijuana use propose , subject acute effect marijuana , also may experience mild withdrawal symptom , measurement one outcome variable test . Subjects must consent random assignment . Women pregnant , nurse childbearing potential practicing effective mean birth control . Subjects evidence history significant hematological , endocrine , cardiovascular , pulmonary , renal , gastrointestinal , neurological disease include diabetes , condition may affect physiological/subjective response . Subjects Addison 's disease , Cushing 's disease diseases adrenal cortex likely affect hormonal/neuroendocrine status . Subjects history current psychotic disorder bipolar affective disorder may interfere subjective measurement . Subjects current major depressive disorder posttraumatic stress disorder disorder associate characteristic change stress response . Subjects receive synthetic glucocorticoid therapy , exogenous steroid therapy , treatment agent interfere hormonal measurement within one month test session . Subjects take psychotropic medication , include SRI 's antidepressant , opiate opiate antagonist may affect test response . Subjects acute illness fever . Individuals otherwise meet study criterion reschedule evaluation participation . Subjects obese ( Â³ 20 % ideal weight ) may interfere hormonal status . Subjects unwilling unable maintain abstinence alcohol drug abuse ( except nicotine ) three day prior stress task procedure . Subjects meet DSMIV criterion substance dependence ( nicotine marijuana ) within past 60 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>marijuana</keyword>
	<keyword>substance abuse</keyword>
	<keyword>drug abuse</keyword>
	<keyword>marijuana dependence</keyword>
	<keyword>drug addiction</keyword>
</DOC>